The National Institutes of Health Experience with Radiolabeled Monoclonal Antibodies: Lymphoma, Melanoma, and Colon Cancer

[1]  S. Larson,et al.  Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience. , 1985, Radiology.

[2]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[3]  I. Royston,et al.  Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. , 1980, Journal of immunology.

[4]  S. Larson,et al.  Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. , 1984, Cancer research.

[5]  S. Larson,et al.  Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3 , 1987, International journal of cancer.

[6]  S. Larson,et al.  Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. , 1984, Cancer treatment reports.

[7]  J. Weinstein,et al.  Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  S. Larson,et al.  Radioimmunoscintigraphy of human colon cancer xenografts in mice with radioiodinated monoclonal antibody B72.3. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  S. Larson A tentative biological model for the localization of radiolabelled antibody in tumor: the importance of immunoreactivity. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[10]  A. Gazdar,et al.  Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody. , 1986, The New England journal of medicine.

[11]  S. Larson,et al.  Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. , 1983, The Journal of clinical investigation.